newsfilter
← Latest News
Business Wire·

Cohen Milstein Sellers & Toll PLLC Announces Investigation of BioMimetic Therapeutics, Inc.

WASHINGTON--(BUSINESS WIRE)--Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether BioMimetic Therapeutics, Inc. (“BioMimetic” or the “Company”) and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.